Literature DB >> 27028552

Liver transplantation in Australia and New Zealand.

Geoffrey W McCaughan1,2,3, Stephen R Munn4,5.   

Abstract

Liver transplantation (LT) in Australia and New Zealand began in 1985. Over this time until December 2014, LT took place in 3700 adults and 800 children. LT is regulated with 1 unit, supported by the government, per state or region. Currently approximately 270 transplants take place per year. Organ donation rates are moderate in Australia (17 per 1 million of population) but very low in New Zealand (11 per 1 million of population). All the units share organ donors for fulminant hepatic failure cases (status 1). Recipient listing criteria and organ allocation criteria are commonly agreed to via National and Trans-Tasman agreements, which are published online. Current survival rates indicate approximately 94% 1-year survival with median survival in adults of approximately 20 years, whereas 75% of children are alive at 20 years. All units collaborate in research projects via the Australia and New Zealand Liver Transplant Registry and have published highly cited articles particularly on the prevention of hepatitis B virus recurrence. Outcomes for indigenous populations have also been analyzed. In conclusion, LT in Australia and New Zealand is well developed with transparent processes related to criteria for listing and organ allocation together with publication of outcomes. Liver Transplantation 22 830-838 2016 AASLD.
© 2016 American Association for the Study of Liver Diseases.

Entities:  

Mesh:

Year:  2016        PMID: 27028552     DOI: 10.1002/lt.24446

Source DB:  PubMed          Journal:  Liver Transpl        ISSN: 1527-6465            Impact factor:   5.799


  7 in total

Review 1.  Hepatocellular carcinoma in older adults: A comprehensive review by Young International Society of Geriatric Oncology.

Authors:  Sukeshi Patel Arora; Gabor Liposits; Susan Caird; Richard F Dunne; Gordon Taylor Moffat; David Okonji; Maria Grazia Rodriquenz; Divyanshu Dua; Efrat Dotan
Journal:  J Geriatr Oncol       Date:  2019-11-06       Impact factor: 3.599

Review 2.  Liver diseases in the Asia-Pacific region: a Lancet Gastroenterology & Hepatology Commission.

Authors:  Shiv K Sarin; Manoj Kumar; Mohammed Eslam; Jacob George; Mamun Al Mahtab; Sheikh M Fazle Akbar; Jidong Jia; Qiuju Tian; Rakesh Aggarwal; David H Muljono; Masao Omata; Yoshihiko Ooka; Kwang-Hyub Han; Hye Won Lee; Wasim Jafri; Amna S Butt; Chern H Chong; Seng G Lim; Raoh-Fang Pwu; Ding-Shinn Chen
Journal:  Lancet Gastroenterol Hepatol       Date:  2019-12-15

Review 3.  Hyperammonemia and lactic acidosis in adults: Differential diagnoses with a focus on inborn errors of metabolism.

Authors:  Michel Tchan
Journal:  Rev Endocr Metab Disord       Date:  2018-03       Impact factor: 6.514

4.  MELD-GRAIL and MELD-GRAIL-Na Are Not Superior to MELD or MELD-Na in Predicting Liver Transplant Waiting List Mortality at a Single-center Level.

Authors:  John D Chetwood; Mark G Wells; Tatiana Tsoutsman; Carlo Pulitano; Michael D Crawford; Ken Liu; Simone I Strasser; Geoffrey W McCaughan; Avik Majumdar
Journal:  Transplant Direct       Date:  2022-06-10

5.  Study design of the DAS-OLT trial: a randomized controlled trial to evaluate the impact of dexmedetomidine on early allograft dysfunction following liver transplantation.

Authors:  Chenlu Ni; Joe Masters; Ling Zhu; Weifeng Yu; Yingfu Jiao; Yuting Yang; Cui Cui; Suqing Yin; Liqun Yang; Bo Qi; Daqing Ma
Journal:  Trials       Date:  2020-06-26       Impact factor: 2.279

6.  Is it safe to expand the indications for split liver transplantation in adults? A single-center analysis of 155 in-situ splits.

Authors:  Ngee-Soon Lau; Mark Ly; Ken Liu; Avik Majumdar; Simone I Strasser; Raaj K Biswas; Geoffrey W McCaughan; Michael Crawford; Carlo Pulitano
Journal:  Clin Transplant       Date:  2022-04-26       Impact factor: 3.456

7.  A decentralised, multidisciplinary model of care facilitates treatment of hepatitis C in regional Australia.

Authors:  Andrew Lee; Josh Hanson; Penny Fox; Greg Spice; Darren Russell; Peter Boyd
Journal:  J Virus Erad       Date:  2018-07-01
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.